222 related articles for article (PubMed ID: 17975020)
1. Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.
Shearer BG; Steger DJ; Way JM; Stanley TB; Lobe DC; Grillot DA; Iannone MA; Lazar MA; Willson TM; Billin AN
Mol Endocrinol; 2008 Feb; 22(2):523-9. PubMed ID: 17975020
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARβ/δ antagonists: Effects on the affinity and selectivity towards PPARβ/δ.
Kaupang Å; Kase ET; Vo CX; Amundsen M; Vik A; Hansen TV
Bioorg Med Chem; 2016 Jan; 24(2):247-60. PubMed ID: 26707845
[TBL] [Abstract][Full Text] [Related]
3. Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery.
Perez Diaz N; Lione LA; Hutter V; Mackenzie LS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808880
[TBL] [Abstract][Full Text] [Related]
4. Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?
Yu J; Berga SL; Zou W; Rajakumar A; Man M; Sidell N; Taylor RN
J Clin Endocrinol Metab; 2020 Sep; 105(9):2983-95. PubMed ID: 32594141
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618.
Kaupang Å; Paulsen SM; Steindal CC; Ravna AW; Sylte I; Halvorsen TG; Thoresen GH; Hansen TV
Eur J Med Chem; 2015 Apr; 94():229-36. PubMed ID: 25768705
[TBL] [Abstract][Full Text] [Related]
6. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
[TBL] [Abstract][Full Text] [Related]
7. Development of improved PPARβ/δ inhibitors.
Toth PM; Naruhn S; Pape VF; Dörr SM; Klebe G; Müller R; Diederich WE
ChemMedChem; 2012 Jan; 7(1):159-70. PubMed ID: 22025402
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
Blitek A; Szymanska M
Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
Bedu E; Wahli W; Desvergne B
Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.
Capozzi ME; Savage SR; McCollum GW; Hammer SS; Ramos CJ; Yang R; Bretz CA; Penn JS
Exp Eye Res; 2020 Jan; 190():107885. PubMed ID: 31758977
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.
Barlaka E; Görbe A; Gáspár R; Pálóczi J; Ferdinandy P; Lazou A
Pharmacol Res; 2015; 95-96():102-10. PubMed ID: 25828396
[TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
15. Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood Samples.
Sibille B; Mothe-Satney I; Le Menn G; Lepouse D; Le Garf S; Baudoin E; Murdaca J; Moratal C; Lamghari N; Chinetti G; Neels JG; Rousseau AS
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768927
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
[TBL] [Abstract][Full Text] [Related]
17. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
19. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
20. Δ
Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
